Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
How does residual DCIS after neoadjuvant chemotherapy impact prognosis if there is a CR of the invasive disease?
Answer from: Radiation Oncologist at Community Practice
The majority of studies suggest residual DCIS has the same outcome as pCR with no invasive disease and thus is still treated as pCR in practice.
Sign In
or
Register
to read more
17488
Related Questions
How do you assess and counsel women with chronic post-lumpectomy or mastectomy pain?
What are your top takeaways in Medical Oncology from SABCS 2024?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
What is the maximum dose that you would give to residual unresectable gross disease in the axilla in the setting of recurrent breast cancer s/p ALND?
How do you advise women to manage wound care for breast brachytherapy needle sites for long term cosmetic outcomes?
How do you manage symptomatic fat necrosis following adjuvant breast radiotherapy?
Is it appropriate to use bolus with hypofractionated PMRT?
In which patients do you utilize a breast MRI as part of the initial workup for breast cancer?
Does delay to the time of lumpectomy impact your decision to omit radiation?
Do you recommend high ozonated oil for radiation dermatitis?